AKEBIA THERAPEUTICS, INC. (AKBA) Total liabilities 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) total liabilities at each fiscal year-end, per SEC filings.
$344.0MFY2025 · since FY2016: $232.1M → $344.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $344.0M | +27.5% |
| FY2024 | $269.9M | -0.9% |
| FY2023 | $272.3M | -22.4% |
| FY2022 | $350.8M | -23.0% |
| FY2021 | $455.3M | +14.8% |
| FY2020 | $396.5M | +5.3% |
| FY2019 | $376.4M | +4.4% |
| FY2018 | $360.6M | +49.2% |
| FY2017 | $241.7M | +4.1% |
| FY2016 | $232.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice